Irvine, CA, United States of America

Karthick Ramyan Mohan

This inventor holds 1 USPTO granted patent. Top assignee: Aventix Medical Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karthick Ramyan Mohan. Retrieved from https://idiyas.com/inventor/karthick-ramyan-mohan-teb930uy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karthick Ramyan Mohan: Innovator in Electroporation Technology

Introduction

Karthick Ramyan Mohan is a notable inventor based in Irvine, California. He has made significant contributions to the field of medical technology, particularly in the area of pulsed field electroporation systems.

Latest Patents

Karthick holds a patent for "Pulsed field electroporation systems and methods." This innovative system includes an expandable member designed to temporarily dilate targeted tissue. It is equipped with one or more Pulsed Field Electroporation (PFE) electrodes that are configured to deliver localized and targeted PFE output at the targeted tissue. This advancement has the potential to enhance medical procedures involving tissue treatment.

Career Highlights

Karthick is currently employed at Aventix Medical Inc., where he continues to develop cutting-edge technologies in the medical field. His work focuses on improving patient outcomes through innovative solutions.

Collaborations

Karthick collaborates with esteemed colleagues such as Raymond L Weiss and James H Atkins, Jr. Their combined expertise contributes to the advancement of medical technologies and innovations.

Conclusion

Karthick Ramyan Mohan is a dedicated inventor whose work in pulsed field electroporation systems showcases his commitment to improving medical technology. His contributions are paving the way for advancements in targeted tissue treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…